Nicotinell Icemint (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Icemint, is a nicotine replacement therapy presented as a chewing gum for buccal use. It delivers a controlled amount of nicotine to the oral mucosa, helping adult smokers who are trying to quit by alleviating withdrawal symptoms and reducing cravings associated with tobacco cessation. The gum is available in a refreshing icemint flavor, which can improve user compliance during the cessation process.

GNH USA supplies Nicotinell Icemint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Icemint, a nicotine replacement therapy, is used to support smoking cessation.

- Adult smokers: reduces cravings and withdrawal symptoms during quit attempts. - Tobacco dependence: provides a controlled nicotine dose to facilitate gradual reduction. - Relapse prevention: helps maintain abstinence after initial cessation.

Nicotinell Icemint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness. - Hiccups or throat discomfort. - Nausea or mild stomach upset. - Increased salivation. - Jaw muscle fatigue from chewing. - Unpleasant taste.

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling. - Chest pain or palpitations. - Irregular heartbeat. - Severe mouth ulceration. - Anaphylaxis (rare).

Before using Nicotinell Icemint, consider the following safety measures.

- Assess nicotine dependence level: tailor use to individual needs. - Avoid use in non‑smokers or occasional smokers: risk of unnecessary nicotine exposure. - Do not exceed recommended chewing time: typically 30 minutes per piece. - Monitor for cardiovascular disease: nicotine may affect heart rate and blood pressure. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotinell Icemint can interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive risk. - Concurrent use of other nicotine replacement products: risk of nicotine overdose. - Strong CYP2A6 inhibitors: may raise nicotine plasma levels.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): may alter nicotine metabolism. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Alcohol: may increase nicotine cravings and affect tolerability.